EHC vs. SEM, CHE, GMED, ELAN, BIO, ROIV, HSIC, PEN, LEGN, and VKTX
Should you be buying Encompass Health stock or one of its competitors? The main competitors of Encompass Health include Select Medical (SEM), Chemed (CHE), Globus Medical (GMED), Elanco Animal Health (ELAN), Bio-Rad Laboratories (BIO), Roivant Sciences (ROIV), Henry Schein (HSIC), Penumbra (PEN), Legend Biotech (LEGN), and Viking Therapeutics (VKTX). These companies are all part of the "medical" sector.
Encompass Health (NYSE:EHC) and Select Medical (NYSE:SEM) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation.
Encompass Health has higher earnings, but lower revenue than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.
Encompass Health received 159 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.83% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.
97.3% of Encompass Health shares are held by institutional investors. Comparatively, 89.5% of Select Medical shares are held by institutional investors. 2.1% of Encompass Health shares are held by company insiders. Comparatively, 19.1% of Select Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Encompass Health has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Select Medical has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500.
In the previous week, Encompass Health had 4 more articles in the media than Select Medical. MarketBeat recorded 11 mentions for Encompass Health and 7 mentions for Select Medical. Select Medical's average media sentiment score of 0.76 beat Encompass Health's score of 0.75 indicating that Select Medical is being referred to more favorably in the news media.
Encompass Health has a net margin of 7.60% compared to Select Medical's net margin of 3.97%. Select Medical's return on equity of 18.11% beat Encompass Health's return on equity.
Encompass Health currently has a consensus target price of $90.29, indicating a potential upside of 5.63%. Select Medical has a consensus target price of $34.25, indicating a potential upside of 0.88%. Given Encompass Health's stronger consensus rating and higher probable upside, research analysts clearly believe Encompass Health is more favorable than Select Medical.
Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.5%. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Select Medical pays out 23.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Summary
Encompass Health beats Select Medical on 15 of the 21 factors compared between the two stocks.
Get Encompass Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Encompass Health Competitors List
Related Companies and Tools